← Back to all trials
Completed
NCT02987153
Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study
Conditions: Spinal Metastases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 22
Sponsor: Northwell Health
Location: Northwell Health Lake Success New York
Summary
Kypho-IORT is a novel approach to combine kyphoplasty, a minimally invasive procedure, with a single dose of intraoperative radiotherapy (IORT) for the treatment of unstable or potentially unstable spinal cord metastases. The primary objective is to evaluate the response rate of pain control when combining kyphoplasty, a minimally invasive procedure, with a single dose of intraoperative radio- therapy (IORT) for the treatment of spinal cord metastases. Secondary objectives are (i.) to determine feasibility for unstable or potential unstable spine metastases; (ii.) to determine tolerability/side effects of the IORT within 90 days post-procedure; (iii.) to determine which clinical factors are prognostic of vertebral compression fracture
Eligibility Criteria
Inclusion Criteria:
* Karnofsky Index ≥ 60.
* History/physical examination within 4 weeks prior to procedure.
* Imaging of the involved spine within 8 weeks prior to procedure to determine the extent of the spine involvement.
* Numerical Rating Pain Scale within 4 week prior to procedure (score must be ≥ 5 for at least one of the planned sites for spinal IORT.
* Neurological examination within 4 week prior to procedure to rule out rapid neurologic decline.
* Spine Instability Neoplastic Score (SINS score) = ≤12.
* Negative serum pregnancy test within 4 weeks prior to procedure for women of childbearing potential.
* Women of childbearing potential and male participants who are sexually active must agree to use a medically effective means of birth control.
* The patient must have localized spine metastasis from the T5 to L5 levels by a screening imaging study \[bone scan, PET, CT, or MRI\] (a solitary spine metastasis; two separate spine levels; or up to 3 separate sites are permitted). Each of the separate sites have a maximal involvement of ONE vertebral body. Patients can have other visceral metastasis.
* Patients must provide study specific informed consent prior to study entry.
Exclusion Criteria:
* Spine instability due to a compression fracture; SINS score \>12.
* Frank spinal cord compression or displacement or epidural compression within 3 mm of the spinal cord
* Patients with rapid neurologic decline
* Bony retropulsion causing neurologic abnormality
* Patients allergic to contrast dye used in MRIs or CT scans or who cannot be premedicated for the use of contrast dye
Source: ClinicalTrials.gov (NCT02987153). StuddyBuddy aggregates publicly available trial information.